Growth Metrics

Enovis (ENOV) Net Income towards Common Stockholders (2010 - 2026)

Enovis (ENOV) reported Net Income towards Common Stockholders of -$39000.0 for Q2 2026, up 68.8% year-over-year from -$23104.3 in Q2 2025, and up 97.64% on a QoQ basis from -$1.7 million in Q4 2025.

Enovis (ENOV) has 17 years of Net Income towards Common Stockholders data on file, last reported at -$39000.0 in Q2 2026.

  • Quarterly Net Income towards Common Stockholders rose 68.8% year-over-year to -$39000.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$1.8 million (down 173.63% YoY) and the FY2025 annual result came in at -$1.9 million, down 173.39% from the prior year.
  • Net Income towards Common Stockholders grew to -$39000.0 in Q2 2026 per ENOV's latest filing, from -$1.7 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $16.6 million in Q3 2023 and bottomed at -$43.7 million in Q3 2022.
  • The 5-year median for Net Income towards Common Stockholders is -$39500.0 (2025), against an average of $556437.5.
  • The widest annual swing landed in 2024, when Net Income towards Common Stockholders surged 3450.0%; it then slumped 487.56% in 2025.
  • Tracing ENOV's Net Income towards Common Stockholders over 5 years: stood at $16.3 million in 2022, then tumbled by 99.93% to $12000.0 in 2023, then surged by 3450.0% to $426000.0 in 2024, then tumbled by 487.56% to -$1.7 million in 2025, then soared by 97.64% to -$39000.0 in 2026.
  • Per Business Quant, the three latest ENOV Net Income towards Common Stockholders figures stand at -$39000.0 (Q2 2026), -$1.7 million (Q4 2025), and -$40000.0 (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.08 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 745.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 187,319.30
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 199.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 411.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Enovis 1.25 Bn 1.22 Bn 365.49 Mn -39,000.00

Historic Data

Download Data 🔒
DateValue
Apr 3, 2026 -39,000.00
Dec 31, 2025 -1.65 Mn
Oct 3, 2025 -40,000.00
Jul 4, 2025 -93,000.00
Apr 4, 2025 -125,000.00
Dec 31, 2024 426,000.00
Sep 27, 2024 2.24 Mn
Jun 28, 2024 -68,000.00
Dec 31, 2023 12,000.00
Sep 29, 2023 16.61 Mn
Jun 30, 2023 4.80 Mn
Mar 31, 2023 -312,000.00
Dec 31, 2022 16.27 Mn
Sep 30, 2022 -527,000.00
Jul 1, 2022 -43.67 Mn
Apr 1, 2022 15.07 Mn
Dec 31, 2021 14.17 Mn
Oct 1, 2021 25.85 Mn
Jul 2, 2021 28.64 Mn
Apr 2, 2021 19.07 Mn
Dec 31, 2020 -51.89 Mn
Oct 2, 2020 13.41 Mn
Jul 3, 2020 -8.47 Mn
Apr 3, 2020 4.48 Mn
Dec 31, 2019 -97.94 Mn
Sep 27, 2019 10.47 Mn
Jun 28, 2019 -469.23 Mn
Mar 29, 2019 -52.02 Mn
Dec 31, 2018 -195.35 Mn
Sep 28, 2018 18.54 Mn
Jun 29, 2018 -6.06 Mn
Mar 30, 2018 8.28 Mn
Dec 31, 2017 -24.59 Mn
Sep 29, 2017 2.08 Mn
Jun 30, 2017 -192.68 Mn
Mar 31, 2017 -197.95 Mn
Dec 31, 2016 37.77 Mn
Sep 30, 2016 27.97 Mn
Jul 1, 2016 39.75 Mn
Apr 1, 2016 22.62 Mn
Dec 31, 2015 44.20 Mn
Sep 25, 2015 18.36 Mn
Jun 26, 2015 53.13 Mn
Mar 27, 2015 52.06 Mn
Dec 31, 2014 80.13 Mn
Sep 26, 2014 73.39 Mn
Jun 27, 2014 191.79 Mn
Mar 28, 2014 24.88 Mn
Dec 31, 2013 31.98 Mn
Sep 27, 2013 50.39 Mn
Jun 28, 2013 53.31 Mn
Mar 29, 2013 22.55 Mn
Dec 31, 2012 14.66 Mn
Sep 28, 2012 4.02 Mn
Jun 29, 2012 7.29 Mn
Mar 30, 2012 -109.33 Mn
Dec 31, 2011 -16.08 Mn
Sep 30, 2011 3.69 Mn
Jul 1, 2011 10.39 Mn
Apr 1, 2011 6.56 Mn
Dec 31, 2010 8.65 Mn
Oct 1, 2010 5.85 Mn
Jul 2, 2010 2.09 Mn